Trending/Dr. David Knopman

Mayo Clinic Q&A podcast: Mayo Clinic experts discuss new Alzheimer’s treatment option
Last week, the Food and Drug Administration approved aducanumab to treat Alzheimer’s disease, which is a progressive brain disorder that is the most common cause…

November 14, 2017
Mayo Clinic Q and A: Lifelong strategies for preventing dementia
Special Topics
Sign up

Mayo Clinic Connect
An online patient support community